Ralf Paschke
Cumming School of Medicine, University of Calgary, Canada
Ralf Paschke served as Division Head of Endocrinology at the University of Calgary, Zone Head of Endocrinology in Calgary from July 2015 to May 2019. In November 2015, he was elected as the chair of the provincial endocrine tumour team in Alberta.
Ralf Paschke spent 4 years as a Heisenberg Professor in a molecular laboratory in the Institute of Interdisciplinary Research at the Universite Libre in Brussels, Belgium working on the molecular etiology of hot thyroid nodules and the mechanism of activation of the TSHR. He was appointed Professor of Internal Medicine and Endocrinology at the University of Leipzig in 1995. His major research interests include thyroid cancer, thyroid nodules, thyroid nodule molecular fine needle cytology (FNAC) diagnostics, the TSH-receptor and diseases caused by TSH-receptor mutations. He trained in Pathology, Internal Medicine and Endocrinology in the university hospitals of Frankfurt, Mannheim and Muenster. He served for 9 years as Director of the Medical Department III at Leipzig University with the sections Endocrinology, Diabetes and Nephrology. He was also the coordinator for endocrine research and deputy chairman of the Interdisciplinary Centre for Clinical Research at the University of Leipzig, Germany. He is the author of more than 350 original journal articles, co-author of several thyroid guidelines and serves on the editorial boards of several journals including Thyroid, European Thyroid Journal and repeatedly the JCEM.
The lecture video：0
Abstract：1
564
0
0
The academic assignments are as follows
| Date (UTC+8) | Time (UTC+8) | Local Time | Room | Session | Role | Talk Title |
|---|---|---|---|---|---|---|
| 2020-12-20 | 10:30-11:10 | 2020-12-20,10:30-11:10 | Room 1 |
Plenary 11 |
Speaker | Molecular Markers as Prognostic Tools to Define Initial Treatment: The Time has Come? |